SCHEMBL22947263

SCHEMBL22947263

c1ccc(-c2nc(-c3ccc(-c4ccc5c(c4)-c4ccccc4S5(c4ccccc4)c4ccccc4)cc3)nc(-c3ccccn3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
TDP1 Q9NUW8 1/20 0.43
RAB9A P51151 5/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
TP53 P04637 3/20 0.41
PKM P14618 3/20 0.41
HPGD P15428 3/20 0.41
LMNA P02545 3/20 0.41
TSHR P16473 3/20 0.41
HSD17B10 Q99714 3/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
KLF5 Q13887 2/20 0.41
NPC1 O15118 4/20 0.37
GRM5 P41594 3/20 0.37
HIF1A Q16665 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947521 0.96 KDM4E (0.44) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL22949299 0.86 MEN1 (0.39) KDM4ERAB9ASMN1; SMN2HPGDLMNA
SCHEMBL22947514 0.85 MEN1 (0.40) KDM4ERAB9ASMN1; SMN2HPGDLMNA
SCHEMBL22949539 0.83 KDM4E (0.43) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL22947357 0.83 KDM4E (0.45) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL22949661 0.81 KDM4E (0.43) KDM4ETDP1RAB9ASMN1; SMN2TP53
SCHEMBL22947695 0.81 MEN1 (0.40) KDM4ERAB9ASMN1; SMN2HPGDLMNA
SCHEMBL22947646 0.81 MEN1 (0.40) KDM4ERAB9ASMN1; SMN2HPGDLMNA
SCHEMBL22949337 0.80 MEN1 (0.43) KDM4ETDP1RAB9AHPGDLMNA
SCHEMBL22947655 0.79 L3MBTL1 (0.42) KDM4ERAB9ASMN1; SMN2TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 KDM4E 3379/4885TDP1 4017/4885RAB9A 2662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.